Skip to content

Author

A. K. Sangtiani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Targeted Therapies and Imaging Biomarkers: Revolutionizing ITP and Coronary Inflammation Management

Precision medicine is increasingly shaping clinical practice in both hematology and cardiology by promoting therapies and diagnostics rooted in disease mechanisms. In immune thrombocytopenia (ITP), rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, represents a targeted strategy that addresses key drivers of the...

A. K. Sangtiani, Barina Khan, Sundal Javed et al. · 0 citations
Open access Aug 2026

Therapeutic Boon or Hidden Bane? Semaglutide for Weight Loss in Non-diabetics

Semaglutide, a long-acting GLP-1 receptor agonist indicated for type 2 diabetes, has recently been approved by the US FDA for chronic weight management in non-diabetic obese patients. It works on GLP-1 receptors in the gut, pancreas, and hypothalamus to stimulate insulin release, decelerate stomach emptying, and augmen...

A. K. Sangtiani, Iqra Qamar, Hassan Shamim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.